KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001860131-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | May 19, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
5,870
Total Value
$27,616.32
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | May 17, 2026 | Exercise/Conversion | 2,419 | โ | โ | 144,966 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | May 18, 2026 | Sale | 1,032 | $26.76 | $27,616.32 | 143,934 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Restricted Stock Unit | Derivative | May 17, 2026 | Exercise/Conversion | 2,419 | $0.00 | $0.00 | 0 | Direct | โ | View Details |